Data Is Leverage: Power, Platforms, and Pharma’s Fight for Control
Healthcare data now drives nearly every modern marketing decision in the pharmaceutical industry. However, as pharmaceutical companies collaborate with EHR vendors, retail platforms, analytics...
26th DTC National Conference
The 26th Annual DTC National Conference will take place April 21–23, 2026, bringing together leaders, innovators, and decision-makers to explore the evolving...
From Prescription to Shelf: Designing the Rx-to-OTC Transition Without Losing Trust
The journey from prescription medicine to store shelf may look simple on the surface, yet executing an effective Rx to OTC pharma marketing strategy...
Winning Before the Table: How Marketing Shapes Payer Negotiations
Payer negotiations rarely begin when executives sit down to discuss contracts. In reality, the groundwork is laid months earlier through positioning, messaging, and evidence...
Forecasting the Uncertain: Why Pharma Marketing Needs Risk-Weighted Strategy
Pharmaceutical marketers often build campaigns around optimistic forecasts rather than risk-adjusted market scenarios. However, markets rarely behave as predicted. Regulatory delays, competitor launches, payer...
From Backorder to Brand Advantage: Marketing Supply Chain Strength in Pharma
Drug shortages, manufacturing audits, and global logistics disruptions are changing how pharmaceutical brands are perceived. When a medication suddenly becomes unavailable, trust erodes quickly....
Prescribed by Code: Pharma Marketing in the Age of Clinical Algorithms
Clinical decisions are no longer shaped only by physician experience or pharmaceutical sales conversations. Increasingly, software tools analyze patient data, clinical guidelines, and treatment...
The Rise of the Institutional Buyer: Rethinking Pharma Marketing for Health Systems
Pharmaceutical marketing is changing quickly. For decades, success depended heavily on influencing individual physicians. However, healthcare consolidation has reshaped the buying landscape. Today, large...
The Subscription Reckoning: Can Pharma Market in a Pay-for-Performance World?
The pharmaceutical industry is entering a new commercial era. For decades, drug pricing and market access were largely driven by volume, formulary placement, and...
Creating the Category: How to Market First-in-Class Therapies Without Confusing the Market
What happens when your brand is so innovative that no one quite understands it yet? That is the paradox at the heart of first-in-class...
